iNKT cells
Showing 1 - 25 of >10,000
Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)
Not yet recruiting
- Hepatocellular Carcinoma
- iNKT Cells
- +2 more
-
Beijing, Beijing, ChinaBeijing Youan Hospital,Capital Medical University
Jul 24, 2023
NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)
Active, not recruiting
- Non-small Cell Lung Cancer
- +5 more
- Infusion of iNKT cells and CD8+T cells
-
Shanghai, Shanghai, ChinaShanghai Public Health Clinical Center
May 6, 2022
Allergic Rhinitis Due to Grass Pollen Trial in Lublin (Ismigen, Placebo)
Completed
- Allergic Rhinitis Due to Grass Pollen
- Ismigen
- Placebo
-
Lublin, PolandDepartment of Pulmonary Diseases and Children Rheumatology, Medi
Apr 2, 2022
Malignant Solid Tumor Trial in Shanghai (Infusion of iNKT cells)
Completed
- Malignant Solid Tumor
- Infusion of iNKT cells
-
Shanghai, ChinaShanghai Public Health Clinical Center, Fudan University
May 6, 2022
Relapsed/Refractory Multiple Myeloma Trial in Louisville, Boston (agenT-797)
Active, not recruiting
- Relapsed/Refractory Multiple Myeloma
-
Louisville, Kentucky
- +2 more
Oct 21, 2022
Natural Killer T Cells ExpressingInvariant T Receptor :
Not yet recruiting
- Systemic Lupus Erythematosus
- Physiopathology
- Blood sample
-
Tours, FranceUniversity Hospital
May 12, 2023
Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (hCD19.IL15.CAR-iNKT)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
-
Xuzhou, Jiangsu, ChinaThe Affiliated hospital of Xuzhou medical University
Mar 24, 2021
Advanced Solid Tumor Trial in Nijmegen (PRECIOUS-01)
Recruiting
- Advanced Solid Tumor
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 26, 2022
Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome Trial in Belgium,
Recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
- Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
-
Antwerpen, Belgium
- +21 more
Sep 27, 2021
Hepatocellular Carcinoma Trial in Beijing (biological, drug, procedure)
Unknown status
- Hepatocellular Carcinoma
- iNKT cells
- +3 more
-
Beijing, Beijing, ChinaBeijing Youan Hospital,Capital Medical University
Jul 5, 2019
Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
- Recipients
- Donors
-
Paris, FranceHopital Necker
Nov 19, 2021
Molecular Basis of Food Allergy
Recruiting
- Food Allergy
- Eosinophilic Esophagitis
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Dec 16, 2021
Systemic Sclerosis Trial in Poitiers (Blood test)
Recruiting
- Systemic Sclerosis
- Blood test
-
Poitiers, FranceCHU poitiers
Mar 1, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Antithymocyte Globulin
- Clofarabine
-
Boston, Massachusetts
- +1 more
Jan 25, 2022
Patients Receiving Biotherapies Targeting IL-23/IL-17 Axis in
Recruiting
- Psoriasis
- Blood sample
- +2 more
-
Paris, Ile De France, FranceLars ROGGE
Oct 6, 2022
Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)
Recruiting
- Pancreatic Cancer
- Stereotactic body radiation therapy plus vNKT cell adoptive therapy
-
Shanghai, ChinaChanghai Hospital affiliated to Naval Medical University
Mar 13, 2023
NSCLC, Melanoma Trial (IMM60, Pembrolizumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- Melanoma
- (no location specified)
Jan 24, 2023
Advanced Therapies for Liver Metastases
Recruiting
- Pancreatic Ductal Adenocarcinoma (PDAC)
- +2 more
-
Milan, ItalyIRCCS San Raffaele
Aug 8, 2022
Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus) Trial in Pessac, Paris (Human T Lymphoid Progenitor (HTLP)
Recruiting
- Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus)
- Human T Lymphoid Progenitor (HTLP) injection
-
Pessac, France
- +1 more
Oct 28, 2021
Lung Transplant Trial in Baltimore, Charlottesville (Regadenoson infusion)
Unknown status
- Lung Transplant
- Regadenoson infusion
-
Baltimore, Maryland
- +1 more
Jun 3, 2020
Melanoma (Skin) Trial in Los Angeles (CP-675,206)
Completed
- Melanoma (Skin)
- CP-675,206
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Oct 1, 2020
Hepatocellular Carcinoma Trial in Beijing (iNKT cells, IL-2, Tegafur)
Unknown status
- Hepatocellular Carcinoma
- iNKT cells
- +2 more
-
Beijing, Beijing, ChinaBeijing Youan Hospital,Capital Medical University
Jan 17, 2018
Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- HER2-Negative Breast Carcinoma
- Biospecimen Collection
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 30, 2023
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Bone Marrow Aspiration
- +10 more
-
Los Angeles, CaliforniaMelanie Ayala Ceja
Jul 10, 2023